BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 25889927)

  • 21. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
    Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc.
    Yuan J; Wang K; Xi M
    Med Sci Monit; 2016 Feb; 22():617-24. PubMed ID: 26908019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
    PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer.
    Zhang W; Wang Q; Yu M; Wu N; Wang H
    Technol Cancer Res Treat; 2014 Apr; 13(2):161-8. PubMed ID: 23919393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.
    Liang Z; Li S; Xu X; Xu X; Wang X; Wu J; Zhu Y; Hu Z; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
    Mol Cells; 2015; 38(2):130-7. PubMed ID: 25556372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MicroRNA-16 regulates the proliferation, invasion and apoptosis of ovarian epithelial carcinoma cells in vitro].
    Tang R; Cui ZM; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):846-50. PubMed ID: 23302126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells.
    Sun G; Shi L; Yan S; Wan Z; Jiang N; Fu L; Li M; Guo J
    Biomed Res Int; 2014; 2014():687826. PubMed ID: 24995320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt-related transcription factor-2.
    Li W; Liu Z; Chen L; Zhou L; Yao Y
    FEBS Lett; 2014 May; 588(9):1608-15. PubMed ID: 24613919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14.
    Li Q; Zhou L; Wang M; Wang N; Li C; Wang J; Qi L
    Biomed Pharmacother; 2018 Feb; 98():636-642. PubMed ID: 29289838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.
    Wang X; Wu J; Lin Y; Zhu Y; Xu X; Xu X; Liang Z; Li S; Hu Z; Zheng X; Xie L
    J Exp Clin Cancer Res; 2014 Sep; 33(1):69. PubMed ID: 25178497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
    Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
    Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of microRNA-21 in the proliferation and apoptosis of ovarian epithelial carcinoma cells].
    Lou YH; Cui ZM; Wang FL; Yang XS
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):684-9. PubMed ID: 22176994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
    Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
    J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTN signaling: Components and mechanistic insights in human ovarian cancer.
    Sethi G; Kwon Y; Burkhalter RJ; Pathak HB; Madan R; McHugh S; Atay S; Murthy S; Tawfik OW; Godwin AK
    Mol Carcinog; 2015 Dec; 54(12):1772-85. PubMed ID: 25418856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
    Mercier PL; Bachvarova M; Plante M; Gregoire J; Renaud MC; Ghani K; TĂȘtu B; Bairati I; Bachvarov D
    Mol Oncol; 2011 Oct; 5(5):438-53. PubMed ID: 21856257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer.
    Hong F; Li Y; Xu Y; Zhu L
    J Int Med Res; 2013 Feb; 41(1):64-71. PubMed ID: 23569131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
    Zhu J; Zhang S; Gu L; Di W
    Carcinogenesis; 2012 Dec; 33(12):2334-43. PubMed ID: 22964660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis.
    Li L; Huang K; You Y; Fu X; Hu L; Song L; Meng Y
    Int J Oncol; 2014 Jun; 44(6):2111-20. PubMed ID: 24715221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.